Prot# Hx-CD4-008: An Open-Label Therapeutic Exploratory Clinical Trial of HuMax-CD4, A Fully Human Monoclonal Anti-CD4 Antibody, in Patients with Advanced Stage (IIA-IVB) Cutaneous T-Cell Lymphoma